Clinical Impact of Using 4% Icodextrin as an Adhesion Prophylactic Agent in High-Risk Gynecological Laparoscopic Surgery on Hospital Readmission and Reoperation Rates: A Retrospective Single-Arm Study
This is the first study ever evaluating hospital readmission/reoperation rates after application of a specific adhesion prophylactic agent. The results indicate that 4% icodextrin is safe and effective when used as an intraperitoneal instillate for reduction in adhesions in gynecological laparoscopic procedures. It has a lower readmission and reoperation rate compared to meta-analysis data in the international literature.
Authors
- Rajesh Devassy (ORCID: https://orcid.org/0000-0001-7795-7749)
- Luz Angela Torres-de la Roche (ORCID: https://orcid.org/0000-0003-1237-4192)
- R L De Wilde
- Maya Sophie de Wilde
- Kaylen Silverberg
- Thamer Alahmad
Institutions
- Pius Hospital Oldenburg (DE)
- Texas Fertility Center (US)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-04-15
- DOI
- https://doi.org/10.3390/jcm15083027
- Primary Topic
- Intestinal and Peritoneal Adhesions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Baxter Healthcare Corporation